The Predictive Significance of Galectin 3 Expression in Patients with Unresectable Non-Small Cell Lung Cancer without EGFR or ALK Mutations Treated Platinum-Based Doublet Chemotherapy

Volume 26, Issue 4, April 2025, Pages 1407-1419

Oussama Aazzane; Abderrahmane Mellouki; Sofia Fathi; Meryem Charkaoui; Saida Stitou; Abdelkader Acharki; Nadia Benchakroun; Souha Sahraoui; Hassan Fellah; Mehdi Karkouri

• View Article
• PDF 1015.21 K

Role of Galectin-3 Combined with Multi- Detector Contrast Enhanced Computed Tomography in Predicting Disease Recurrence in Patients with Ovarian Cancer

Volume 18, Issue 5, May 2017, Pages 1277-1282

Emanuela Anastasi; Silvia Gigli; Maria Santulli; Sara Tartaglione; Laura Ballesio; Maria Grazia Porpora; Teresa Granato; Carlo Catalano; Antonio Angeloni; Lucia Manganaro

• View Article
• PDF 312.03 K

Serum Anti-Gal-3 Autoantibody is a Predictive Marker of the Efficacy of Platinum-Based Chemotherapy against Pulmonary Adenocarcinoma

Volume 16, Issue 17, December 2015, Pages 7959-7965

• View Article
• PDF 2.1 M

Synergistic Effects of PectaSol-C Modified Citrus Pectin an Inhibitor of Galectin-3 and Paclitaxel on Apoptosis of Human SKOV-3 Ovarian Cancer Cells

Volume 14, Issue 12, December 2013, Pages 7561-7568

• View Article
• PDF 1.18 M